However, unlike MS, where glial fibrillary acidic protein (GFAP) expression in lesions is typically upregulated [49], NMOSD lesions exhibit a loss of GFAP-positive astrocytes [50, 51]. The gene discussed is GFAP; the disease is myeloid sarcoma.